COMBINACION QUE COMPRENDE UN ANTIPSICOTICO Y (2S)-(4E)-N-METIL-5-[3-(5-ISOPROPOXIPIRIDIN)IL]-4-PENTEN-2-AMINA; COMPOSICION FARMACEUTICA QUE LA COMPRENDE; KIT FARMACEUTICO; Y USO PARA TRATAR PERJUICIO COGNITIVO Y/O TRASTORNO PSICOTICOS

COMBINACION QUE COMPRENDE UN ANTIPSICOTICO Y (2S)-(4E)-N-METIL-5-[3-(5-ISOPROPOXIPIRIDIN)IL]-4-PENTEN-2-AMINA; COMPOSICION FARMACEUTICA QUE LA COMPRENDE; KIT FARMACEUTICO; Y USO PARA TRATAR PERJUICIO COGNITIVO Y/O TRASTORNO PSICOTICOS

The present invention provides a combination of (a) an antipsychotic and (b) an alpha4/beta2 (alpha4beta2)-neuronal nicotinic receptor agonist. The invention further relates to pharmaceutical compositions comprising said combination and to the use of the combination in therapy. The invention further...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: EVENDEN JOHN L.,JOHNSON EDWING,MRZLJAK LASILAW,WIDZOWSKI DAN,JORGAN KRISTEN G.,BREINING SCOTT R.,LETCHWORTH SHARON R.,M
Format: Patent
Sprache:spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator EVENDEN JOHN L.,JOHNSON EDWING,MRZLJAK LASILAW,WIDZOWSKI DAN,JORGAN KRISTEN G.,BREINING SCOTT R.,LETCHWORTH SHARON R.,M
description The present invention provides a combination of (a) an antipsychotic and (b) an alpha4/beta2 (alpha4beta2)-neuronal nicotinic receptor agonist. The invention further relates to pharmaceutical compositions comprising said combination and to the use of the combination in therapy. The invention further relates to a kit comprising the combination and use of said kit in therapy.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CL2007002684A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CL2007002684A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CL2007002684A13</originalsourceid><addsrcrecordid>eNqNjk1Lw0AQhnPxIOp_WOglOQzGNFUhp3G71anJzHY_RBEpRdaTaKH-an-Fm6Lo0cMyLPPO87yHxaeW4YoYNQmrVTQq_60zPDcqskIOZD1pCfmpB1U2voKyNRUwDCZQDzN4nEI5A_JinVi5J0uO5sQV9U_QgjUcDEMDOGRLt8dLJo66BboBtYkZjnt3j7_6Tt1S-BuRLheIXpRFhyo4DOiUNW4ZR1o-vGYKdJdrnsq49kEc5_RPfX9cHLxsXnfp5HseFZOFCfoG0vZ9nXbbzXN6Sx9r3Td1fVHXzflli2fT_6W-AL2PWSo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINACION QUE COMPRENDE UN ANTIPSICOTICO Y (2S)-(4E)-N-METIL-5-[3-(5-ISOPROPOXIPIRIDIN)IL]-4-PENTEN-2-AMINA; COMPOSICION FARMACEUTICA QUE LA COMPRENDE; KIT FARMACEUTICO; Y USO PARA TRATAR PERJUICIO COGNITIVO Y/O TRASTORNO PSICOTICOS</title><source>esp@cenet</source><creator>EVENDEN JOHN L.,JOHNSON EDWING,MRZLJAK LASILAW,WIDZOWSKI DAN,JORGAN KRISTEN G.,BREINING SCOTT R.,LETCHWORTH SHARON R.,M</creator><creatorcontrib>EVENDEN JOHN L.,JOHNSON EDWING,MRZLJAK LASILAW,WIDZOWSKI DAN,JORGAN KRISTEN G.,BREINING SCOTT R.,LETCHWORTH SHARON R.,M</creatorcontrib><description>The present invention provides a combination of (a) an antipsychotic and (b) an alpha4/beta2 (alpha4beta2)-neuronal nicotinic receptor agonist. The invention further relates to pharmaceutical compositions comprising said combination and to the use of the combination in therapy. The invention further relates to a kit comprising the combination and use of said kit in therapy.</description><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080627&amp;DB=EPODOC&amp;CC=CL&amp;NR=2007002684A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080627&amp;DB=EPODOC&amp;CC=CL&amp;NR=2007002684A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>EVENDEN JOHN L.,JOHNSON EDWING,MRZLJAK LASILAW,WIDZOWSKI DAN,JORGAN KRISTEN G.,BREINING SCOTT R.,LETCHWORTH SHARON R.,M</creatorcontrib><title>COMBINACION QUE COMPRENDE UN ANTIPSICOTICO Y (2S)-(4E)-N-METIL-5-[3-(5-ISOPROPOXIPIRIDIN)IL]-4-PENTEN-2-AMINA; COMPOSICION FARMACEUTICA QUE LA COMPRENDE; KIT FARMACEUTICO; Y USO PARA TRATAR PERJUICIO COGNITIVO Y/O TRASTORNO PSICOTICOS</title><description>The present invention provides a combination of (a) an antipsychotic and (b) an alpha4/beta2 (alpha4beta2)-neuronal nicotinic receptor agonist. The invention further relates to pharmaceutical compositions comprising said combination and to the use of the combination in therapy. The invention further relates to a kit comprising the combination and use of said kit in therapy.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjk1Lw0AQhnPxIOp_WOglOQzGNFUhp3G71anJzHY_RBEpRdaTaKH-an-Fm6Lo0cMyLPPO87yHxaeW4YoYNQmrVTQq_60zPDcqskIOZD1pCfmpB1U2voKyNRUwDCZQDzN4nEI5A_JinVi5J0uO5sQV9U_QgjUcDEMDOGRLt8dLJo66BboBtYkZjnt3j7_6Tt1S-BuRLheIXpRFhyo4DOiUNW4ZR1o-vGYKdJdrnsq49kEc5_RPfX9cHLxsXnfp5HseFZOFCfoG0vZ9nXbbzXN6Sx9r3Td1fVHXzflli2fT_6W-AL2PWSo</recordid><startdate>20080627</startdate><enddate>20080627</enddate><creator>EVENDEN JOHN L.,JOHNSON EDWING,MRZLJAK LASILAW,WIDZOWSKI DAN,JORGAN KRISTEN G.,BREINING SCOTT R.,LETCHWORTH SHARON R.,M</creator><scope>EVB</scope></search><sort><creationdate>20080627</creationdate><title>COMBINACION QUE COMPRENDE UN ANTIPSICOTICO Y (2S)-(4E)-N-METIL-5-[3-(5-ISOPROPOXIPIRIDIN)IL]-4-PENTEN-2-AMINA; COMPOSICION FARMACEUTICA QUE LA COMPRENDE; KIT FARMACEUTICO; Y USO PARA TRATAR PERJUICIO COGNITIVO Y/O TRASTORNO PSICOTICOS</title><author>EVENDEN JOHN L.,JOHNSON EDWING,MRZLJAK LASILAW,WIDZOWSKI DAN,JORGAN KRISTEN G.,BREINING SCOTT R.,LETCHWORTH SHARON R.,M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CL2007002684A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2008</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>EVENDEN JOHN L.,JOHNSON EDWING,MRZLJAK LASILAW,WIDZOWSKI DAN,JORGAN KRISTEN G.,BREINING SCOTT R.,LETCHWORTH SHARON R.,M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>EVENDEN JOHN L.,JOHNSON EDWING,MRZLJAK LASILAW,WIDZOWSKI DAN,JORGAN KRISTEN G.,BREINING SCOTT R.,LETCHWORTH SHARON R.,M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINACION QUE COMPRENDE UN ANTIPSICOTICO Y (2S)-(4E)-N-METIL-5-[3-(5-ISOPROPOXIPIRIDIN)IL]-4-PENTEN-2-AMINA; COMPOSICION FARMACEUTICA QUE LA COMPRENDE; KIT FARMACEUTICO; Y USO PARA TRATAR PERJUICIO COGNITIVO Y/O TRASTORNO PSICOTICOS</title><date>2008-06-27</date><risdate>2008</risdate><abstract>The present invention provides a combination of (a) an antipsychotic and (b) an alpha4/beta2 (alpha4beta2)-neuronal nicotinic receptor agonist. The invention further relates to pharmaceutical compositions comprising said combination and to the use of the combination in therapy. The invention further relates to a kit comprising the combination and use of said kit in therapy.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_CL2007002684A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COMBINACION QUE COMPRENDE UN ANTIPSICOTICO Y (2S)-(4E)-N-METIL-5-[3-(5-ISOPROPOXIPIRIDIN)IL]-4-PENTEN-2-AMINA; COMPOSICION FARMACEUTICA QUE LA COMPRENDE; KIT FARMACEUTICO; Y USO PARA TRATAR PERJUICIO COGNITIVO Y/O TRASTORNO PSICOTICOS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A07%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=EVENDEN%20JOHN%20L.,JOHNSON%20EDWING,MRZLJAK%20LASILAW,WIDZOWSKI%20DAN,JORGAN%20KRISTEN%20G.,BREINING%20SCOTT%20R.,LETCHWORTH%20SHARON%20R.,M&rft.date=2008-06-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECL2007002684A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true